Cargando…
Modulating effect of the PI3-kinase inhibitor LY294002 on cisplatin in human pancreatic cancer cells
BACKGROUND: Chemoresistance is a serious problem in pancreatic cancer, but the mechanism of resistance and strategies against the resistance have not been elucidated. We examined the potential of the phosphatidylinositol 3-kinase (PI3K)/Akt inhibitor LY294002 to enhance the anti-tumor effect of cisp...
Autores principales: | Fujiwara, Masao, Izuishi, Kunihiko, Sano, Takanori, Hossain, Mohammad Akram, Kimura, Shoji, Masaki, Tsutomu, Suzuki, Yasuyuki |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2607265/ https://www.ncbi.nlm.nih.gov/pubmed/19032736 http://dx.doi.org/10.1186/1756-9966-27-76 |
Ejemplares similares
-
LY 294002 inhibits adenosine receptor activation by a mechanism independent of effects on PI-3 kinase or casein kinase II
por: Searl, T. J., et al.
Publicado: (2005) -
Synergistic Lethality of Mifepristone and LY294002 in Ovarian Cancer Cells
por: Wempe, Stacy L., et al.
Publicado: (2013) -
Phosphatidylinositol 3-kinase inhibitor(LY294002) induces apoptosis of human nasopharyngeal carcinoma in vitro and in vivo
por: Jiang, Hanguo, et al.
Publicado: (2010) -
LY294002 inhibits the Warburg effect in gastric cancer cells by downregulating pyruvate kinase M2
por: Lu, Jian, et al.
Publicado: (2018) -
Encapsulation of PI3K Inhibitor LY294002 within Polymer Nanoparticles Using Ion Pairing Flash Nanoprecipitation
por: Fergusson, Austin D., et al.
Publicado: (2023)